BENEVI
DEAD

Serial Number

86793518

Owner

BeneVi Health LLC

Attorney

Devon E. White

Filing Date

Oct 20, 2015

Add to watchlist:

No watchlists yet
View on USPTO

BENEVI Trademark

Serial Number: 86793518

BENEVI is a trademark filed by BeneVi Health LLC on October 20, 2015. The trademark is classified under Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BeneVi Health LLC (4 trademarks)

11800 Weston Parkway
Cary, NC 27513

Entity Type: 16

Trademark Details

Filing Date

October 20, 2015

Registration Date

Not Registered

Published for Opposition

September 20, 2016

Goods & Services

mail order services in the field of prescription drugs, biologics/biotechnology goods, and medical devices; mail order pharmacy services; business management of reimbursement programs; Business services, namely, reimbursement reporting in the field of prescription drugs, biologics/biotechnology goods, and medical devices; Managed care services, namely, utilization review and pre-certification services; Evidenced-based health care cost management services and healthcare utilization and review services; Retail pharmacy services, namely, coordinating filling and refilling prescriptions, generating reports to patients, prescribers, and care givers regarding prescriptions, and assisting with pharmaceutical drug billing; Pharmaceutical distributorship services; Retail pharmacy distribution services featuring a patient assistance program; Retail pharmacy services featuring free starter drug programs; Pharmaceutical cost management advisory, reimbursement management, and consulting services and drug utilization review advisory and consulting services; Business consulting and management in the field of clinical trials, namely clinical trial supply and material logistical management; Business consulting and management, namely, clinical trial drug logistics and distribution; Providing comprehensive management services to pharmaceutical companies, namely, business management services for benefit eligibility services, prior authorization of medical and pharmacy services, 24 hour nurse care managers services; Patient assistance program, namely, providing business and cost management information regarding drug cost reimbursement and providing billing assistance and free drug distribution; Specialty care management and prescription services, namely, specialty pharmacy services and arranging of managed care contractual services in the fields of specialty pharmacy services; business administration of a regulatory compliance medication enrollment program in the field of prescription medicine by maintaining a risk evaluation and mitigation strategy registry and providing record keeping services to ensure the proper prescribing and dispensing of pharmaceuticals for physicians, pharmacists and patients; distributorship services in the field of pharmaceuticals; business management of personalized wellness and healthcare care programs to specialty care and non-specialty care members, through member healthcare management provided by specialized clinicians

providing patient advocate and case management services, namely, the coordination of necessary medical services for persons with medical conditions requiring specialized care or resulting from catastrophic events; regulatory compliance consulting and related information for prescription drugs in the nature of providing information on misuse risk evaluation and mitigation strategies for prescription drugs and facilitating the exchange of information between patients and drug prescribers

Providing medical record analysis and assessments that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Patient medication care management, nursing and medication adherence services, namely, communicating with patients regarding their medications, adherence to medication regimens, medication side-effects, allergic sensitivity, drug interactions, or other issues related to medication tolerance, alternate medication brands or generics, dosage or manner of taking medications; Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues and health awareness; patient assistance program to provide drugs and medical services at a reduced cost to low-income patients without prescription drug coverage or health insurance coverage; Specialty care management services, namely, providing wellness services in the nature of personal health assessments; Comprehensive health care services in the field of chronic illnesses; healthcare services, namely, disease management programs for chronically ill persons; health risk assessment services; providing personalized healthcare and wellness programs to specialty care and non-specialty care members, that feature member healthcare management provided by specialized clinicians; providing medical and health care related information about prescription drugs as it relates to the misuse risk evaluation and mitigation strategies for prescription drugs and facilitating the exchange of information between patients and drug prescribers

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 19, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 19, 2017 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 15, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 10, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 10, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 10, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 10, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2016 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2016 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2016 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 23, 2015 NWOS
NEW APPLICATION ENTERED
Oct 23, 2015 NWAP